Advertisement

Malaise, Weight Loss and Intermittent Fever

  • Ross Petty
  • Farhad Salehzadeh
  • Marco Antonio Yamazaki-Nakashimada
Chapter

Abstract

  • Antibodies against native or double stranded DNA (anti-dsDNA) or extractable nuclear antigens (anti-ENAs) are specific for systemic lupus erythematosus

  • Negative antinuclear antibody (ANA) in children suspected for systemic lupus erythematosus rules out the diagnosis

  • C3, C4 complement level or total hemolytic complement with CH50 give a measure of disease activity in SLE

Keywords

Anti-double stranded DNA Antinuclear antibody Systemic lupus erythematosus 

References

  1. 1.
    Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.CrossRefGoogle Scholar
  2. 2.
    Birmingham DJ, Irshaid F, Nagaraja HN, Zou X, Tsao BP, Wu H, Yu CY, Hebert LA, Rovin BH. The complex nature of serum C3 and C4 as biomarkers of lupus renal flare. Lupus. 2010;19(11):1272–80.CrossRefGoogle Scholar
  3. 3.
    Weening JJ, D’Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol. 2004;15(2):241–50.CrossRefGoogle Scholar
  4. 4.
    Houssiau FA, Vasconcelos C, D’Cruz D, Sebastiani GD, Garrido Ed Ede R, Danieli MG, Abramovicz D, Blockmans D, Mathieu A, Direskeneli H, Galeazzi M, Gul A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. Arthritis Rheum. 2002;46(8):2121–31.CrossRefGoogle Scholar
  5. 5.
    Henderson L, Masson P, Craig JC, Flanc RS, Roberts MA, Strippoli GF, Webster AC. Treatment for lupus nephritis. Cochrane Database Syst Rev. 2012;12:Cd002922.PubMedGoogle Scholar
  6. 6.
    Pons-Estel GJ, Alarcon GS, McGwin G Jr, Danila MI, Zhang J, Bastian HM, Reveille JD, Vila LM. Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort. Arthritis Rheum. 2009;61(6):830–9.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Ross Petty
    • 1
  • Farhad Salehzadeh
    • 2
  • Marco Antonio Yamazaki-Nakashimada
    • 3
  1. 1.Pediatric RheumatologyUniversity of British ColumbiaVancouverCanada
  2. 2.Pediatric RheumatologyBouali Children’s Hospital, ARUMSArdabilIran
  3. 3.Clinical Immunology DepartmentInstituto Nacional de PediatríaMexico CityMexico

Personalised recommendations